These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis. Randerath K, Liehr JG, Gladek A, Randerath E. IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347 [Abstract] [Full Text] [Related]
6. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts. Haack T, Boche G, Kliem C, Wiessler M, Albert D, Schmeiser HH. Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898 [Abstract] [Full Text] [Related]
7. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis. Reddy MV, Irvin TR, Randerath K. Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087 [Abstract] [Full Text] [Related]
8. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Reddy MV, Gupta RC, Randerath E, Randerath K. Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441 [Abstract] [Full Text] [Related]
9. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts. Randerath K, Randerath E, Agrawal HP, Reddy MV. IARC Sci Publ; 1984 Feb; (59):217-31. PubMed ID: 6443609 [Abstract] [Full Text] [Related]
15. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine. Otteneder M, Eder E, Lutz WK. Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023 [Abstract] [Full Text] [Related]
19. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications. Randerath K, Randerath E. J UOEH; 1989 Mar 20; 11 Suppl():368-86. PubMed ID: 2664950 [Abstract] [Full Text] [Related]